(-)-demecolcine increases expression ISO LY96 (Homo sapiens) 6480464 Demecolcine results in increased expression of LY96 mRNA CTD PMID:23649840 1,2-dimethylhydrazine decreases expression ISO Ly96 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of LY96 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LY96 mRNA CTD PMID:25380136 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ly96 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of LY96 mRNA CTD PMID:21570461 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO LY96 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2-palmitoylglycerol increases expression ISO LY96 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of LY96 mRNA CTD PMID:37199045 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Ly96 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LY96 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of LY96 mRNA CTD PMID:25380136 and PMID:30723492 4,4'-sulfonyldiphenol multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 4-hydroxynon-2-enal increases expression ISO Ly96 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of LY96 mRNA CTD PMID:19191707 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LY96 mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of LY96 mRNA CTD PMID:31881176 adenosine increases expression ISO LY96 (Homo sapiens) 6480464 Adenosine results in increased expression of LY96 mRNA CTD PMID:21538184 aflatoxin B1 affects expression ISO LY96 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of LY96 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO LY96 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of LY96 mRNA CTD PMID:21632981 and PMID:21641981 Aflatoxin B2 alpha decreases methylation ISO LY96 (Homo sapiens) 6480464 aflatoxin B2 results in decreased methylation of LY96 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO Ly96 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 aldehydo-D-glucose increases expression ISO Ly96 (Mus musculus) 6480464 Glucose results in increased expression of LY96 mRNA CTD PMID:33448797 amitrole increases expression EXP 6480464 Amitrole results in increased expression of LY96 mRNA CTD PMID:30047161 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of LY96 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO LY96 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of LY96 mRNA CTD PMID:24449571 arsane multiple interactions ISO LY96 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO LY96 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO LY96 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to LY96 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO LY96 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LY96 mRNA CTD PMID:26705709 and PMID:27829220 arsenous acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA CTD PMID:25913414 atazanavir sulfate multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of LY96 mRNA CTD PMID:33819548 azathioprine increases expression ISO LY96 (Homo sapiens) 6480464 Azathioprine results in increased expression of LY96 mRNA CTD PMID:22623647 benzene increases expression ISO LY96 (Homo sapiens) 6480464 Benzene results in increased expression of LY96 mRNA CTD PMID:33064461 benzo[a]pyrene increases expression ISO Ly96 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of LY96 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO LY96 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of LY96 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO LY96 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LY96 intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO LY96 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of LY96 mRNA CTD PMID:20106945 more ... benzo[e]pyrene decreases methylation ISO LY96 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of LY96 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide increases expression ISO LY96 (Homo sapiens) 6480464 Mustard Gas results in increased expression of LY96 mRNA CTD PMID:25102026 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LY96 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO LY96 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LY96 gene CTD PMID:31601247 bisphenol A affects binding ISO LY96 (Homo sapiens) 6480464 bisphenol A binds to [TLR4 protein binds to LY96 protein] CTD PMID:33706241 bisphenol A increases expression ISO LY96 (Homo sapiens) 6480464 bisphenol A results in increased expression of LY96 mRNA CTD PMID:25047013 and PMID:27685785 bortezomib multiple interactions ISO LY96 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA CTD PMID:25913414 butanal increases expression ISO LY96 (Homo sapiens) 6480464 butyraldehyde results in increased expression of LY96 mRNA CTD PMID:26079696 cadmium atom increases expression ISO LY96 (Homo sapiens) 6480464 Cadmium results in increased expression of LY96 mRNA CTD PMID:21120746 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of LY96 promoter CTD PMID:22457795 cadmium dichloride increases expression ISO Ly96 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of LY96 mRNA CTD PMID:26352046 calcitriol increases expression ISO LY96 (Homo sapiens) 6480464 Calcitriol results in increased expression of LY96 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO LY96 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LY96 mRNA CTD PMID:21592394 cannabidiol decreases expression ISO LY96 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of LY96 mRNA CTD PMID:27932991 carbon nanotube increases expression ISO Ly96 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of LY96 mRNA CTD PMID:25554681 chenodeoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 chlorpyrifos increases expression ISO Ly96 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of LY96 mRNA CTD PMID:37019170 cobalt dichloride multiple interactions ISO LY96 (Homo sapiens) 6480464 cobaltous chloride results in increased activity of [TLR4 protein binds to LY96 protein] CTD PMID:25803856 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of LY96 mRNA CTD PMID:24386269 copper atom multiple interactions ISO LY96 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of LY96 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO LY96 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of LY96 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO LY96 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of LY96 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO LY96 (Homo sapiens) 6480464 Cyclosporine results in increased expression of LY96 mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of LY96 mRNA CTD PMID:33819548 D-glucose increases expression ISO Ly96 (Mus musculus) 6480464 Glucose results in increased expression of LY96 mRNA CTD PMID:33448797 D-glucose multiple interactions ISO Ly96 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 deoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 dexamethasone multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO LY96 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA CTD PMID:25913414 diarsenic trioxide increases expression ISO LY96 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LY96 mRNA CTD PMID:26705709 and PMID:27829220 dioxygen multiple interactions ISO Ly96 (Mus musculus) 6480464 LY96 results in increased susceptibility to [Oxygen deficiency co-treated with Blood Glucose deficiency] CTD PMID:28063877 diuron decreases expression ISO LY96 (Homo sapiens) 6480464 Diuron results in decreased expression of LY96 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO LY96 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with Fungal Polysaccharides] results in decreased expression of LY96 mRNA CTD PMID:27181935 doxorubicin decreases expression ISO LY96 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of LY96 mRNA CTD PMID:29803840 epoxiconazole increases expression ISO Ly96 (Mus musculus) 6480464 epoxiconazole results in increased expression of LY96 mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of LY96 mRNA CTD PMID:28852734 ethanol multiple interactions EXP 6480464 platycodin D inhibits the reaction [Ethanol results in increased expression of LY96 mRNA] CTD PMID:28852734 ethyl methanesulfonate increases expression ISO LY96 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of LY96 mRNA CTD PMID:23649840 ferroheme b affects binding ISO Ly96 (Mus musculus) 6480464 Heme binds to LY96 protein CTD PMID:36115635 ferroheme b multiple interactions ISO Ly96 (Mus musculus) 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Heme promotes the reaction [TLR4 protein binds to LY96 protein]] more ... CTD PMID:36115635 fluoranthene multiple interactions ISO Ly96 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of LY96 mRNA CTD PMID:28329830 folic acid increases expression ISO LY96 (Homo sapiens) 6480464 Folic Acid deficiency results in increased expression of LY96 mRNA CTD PMID:28752528 folic acid decreases expression ISO LY96 (Homo sapiens) 6480464 Folic Acid results in decreased expression of LY96 mRNA CTD PMID:28752528 formaldehyde increases expression ISO LY96 (Homo sapiens) 6480464 Formaldehyde results in increased expression of LY96 mRNA CTD PMID:23649840 and PMID:27664576 fucoxanthin multiple interactions ISO Ly96 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 fulvestrant multiple interactions ISO LY96 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LY96 gene CTD PMID:31601247 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LY96 mRNA CTD PMID:22061828 glucose multiple interactions ISO Ly96 (Mus musculus) 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of LY96 mRNA] CTD PMID:33448797 glucose increases expression ISO Ly96 (Mus musculus) 6480464 Glucose results in increased expression of LY96 mRNA CTD PMID:33448797 glycochenodeoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA more ... CTD PMID:33819548 glycyrrhetinate multiple interactions ISO Ly96 (Mus musculus) 6480464 Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]] CTD PMID:28213090 glycyrrhetinic acid multiple interactions ISO Ly96 (Mus musculus) 6480464 Glycyrrhetinic Acid inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased expression of [TLR4 protein binds to LY96 protein]] CTD PMID:28213090 heme b affects binding ISO Ly96 (Mus musculus) 6480464 Heme binds to LY96 protein CTD PMID:36115635 heme b multiple interactions ISO Ly96 (Mus musculus) 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Heme promotes the reaction [TLR4 protein binds to LY96 protein]] more ... CTD PMID:36115635 hydrogen peroxide increases expression ISO LY96 (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of LY96 mRNA CTD PMID:34581912 hydroquinone increases expression ISO LY96 (Homo sapiens) 6480464 hydroquinone results in increased expression of LY96 mRNA CTD PMID:31256213 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of LY96 mRNA CTD PMID:21396975 indometacin multiple interactions ISO LY96 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LY96 mRNA CTD PMID:28628672 lead diacetate increases expression ISO Ly96 (Mus musculus) 6480464 lead acetate results in increased expression of LY96 mRNA CTD PMID:20542052 lipopolysaccharide decreases response to substance ISO LY96 (Homo sapiens) 6480464 LY96 exon mutant form results in decreased susceptibility to Lipopolysaccharides and LY96 protein mutant form results in decreased susceptibility to Lipopolysaccharides CTD PMID:16367934 lipopolysaccharide increases expression ISO LY96 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of LY96 mRNA CTD PMID:26037075 lipopolysaccharide affects binding ISO LY96 (Homo sapiens) 6480464 Lipopolysaccharides binds to [TLR4 protein binds to LY96 protein] and Lipopolysaccharides binds to LY96 protein CTD PMID:26037075 and PMID:28063877 lipopolysaccharide increases response to substance ISO Ly96 (Mus musculus) 6480464 LY96 protein results in increased susceptibility to Lipopolysaccharides CTD PMID:16367934 lipopolysaccharide multiple interactions ISO LY96 (Homo sapiens) 6480464 1-(3 more ... CTD PMID:20700758 more ... melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [tetrachlorobenzoquinone results in increased expression of LY96 protein] more ... CTD PMID:27413111 and PMID:28238930 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of LY96 mRNA CTD PMID:16507785 methamphetamine increases expression ISO LY96 (Homo sapiens) 6480464 Methamphetamine results in increased expression of LY96 mRNA CTD PMID:25290377 methapyrilene decreases methylation ISO LY96 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of LY96 intron CTD PMID:30157460 methimazole increases expression EXP 6480464 Methimazole results in increased expression of LY96 mRNA CTD PMID:30047161 methotrexate decreases expression ISO LY96 (Homo sapiens) 6480464 Methotrexate results in decreased expression of LY96 mRNA CTD PMID:17400583 methyl methanesulfonate increases expression ISO LY96 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of LY96 mRNA CTD PMID:23649840 Morroniside affects binding ISO Ly96 (Mus musculus) 6480464 morroniside binds to [TLR4 protein binds to LY96 protein] CTD PMID:34029560 N-methylformamide affects expression ISO Ly96 (Mus musculus) 6480464 methylformamide affects the expression of LY96 mRNA and methylformamide analog affects the expression of LY96 mRNA CTD PMID:17040096 N-nitrosodiethylamine increases expression ISO LY96 (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of LY96 mRNA CTD PMID:21527772 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LY96 mRNA CTD PMID:25380136 nefazodone multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of LY96 mRNA CTD PMID:33819548 nickel dichloride multiple interactions ISO LY96 (Homo sapiens) 6480464 nickel chloride results in increased activity of [TLR4 protein binds to LY96 protein] CTD PMID:25803856 O-methyleugenol increases expression ISO LY96 (Homo sapiens) 6480464 methyleugenol results in increased expression of LY96 mRNA CTD PMID:32234424 paracetamol affects expression ISO Ly96 (Mus musculus) 6480464 Acetaminophen affects the expression of LY96 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of LY96 mRNA CTD PMID:33819548 paracetamol multiple interactions ISO Ly96 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of LY96 mRNA] CTD PMID:29246445 paracetamol increases expression ISO Ly96 (Mus musculus) 6480464 Acetaminophen results in increased expression of LY96 mRNA CTD PMID:29246445 paracetamol decreases expression ISO LY96 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of LY96 mRNA CTD PMID:21420995 and PMID:26690555 paraquat increases expression ISO LY96 (Homo sapiens) 6480464 Paraquat results in increased expression of LY96 mRNA CTD PMID:34097952 and PMID:34681664 perfluorooctane-1-sulfonic acid multiple interactions ISO Ly96 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LY96 mRNA CTD PMID:36331819 phenobarbital multiple interactions ISO Ly96 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LY96 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO Ly96 (Mus musculus) 6480464 Phenobarbital results in increased expression of LY96 mRNA CTD PMID:19270015 and PMID:19482888 phenylmercury acetate multiple interactions ISO LY96 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA CTD PMID:27188386 platycodin D multiple interactions EXP 6480464 platycodin D inhibits the reaction [Ethanol results in increased expression of LY96 mRNA] CTD PMID:28852734 prednisolone decreases expression ISO LY96 (Homo sapiens) 6480464 Prednisolone results in decreased expression of LY96 mRNA CTD PMID:17379860 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of LY96 mRNA CTD PMID:30047161 procyanidin B1 affects binding ISO LY96 (Homo sapiens) 6480464 procyanidin B1 binds to [TLR4 protein binds to LY96 protein] CTD PMID:26037075 procyanidin B1 multiple interactions ISO LY96 (Homo sapiens) 6480464 procyanidin B1 inhibits the reaction [Lipopolysaccharides results in increased expression of LY96 mRNA] CTD PMID:26037075 propanal increases expression ISO LY96 (Homo sapiens) 6480464 propionaldehyde results in increased expression of LY96 mRNA CTD PMID:26079696 quercetin increases expression ISO LY96 (Homo sapiens) 6480464 Quercetin results in increased expression of LY96 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO LY96 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LY96 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO LY96 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of LY96 mRNA and Silicon Dioxide results in increased expression of LY96 mRNA CTD PMID:25351596 more ... silver atom increases expression ISO LY96 (Homo sapiens) 6480464 Silver results in increased expression of LY96 mRNA CTD PMID:22342292 silver(0) increases expression ISO LY96 (Homo sapiens) 6480464 Silver results in increased expression of LY96 mRNA CTD PMID:22342292 sodium arsenate multiple interactions ISO LY96 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LY96 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO LY96 (Homo sapiens) 6480464 sodium arsenite results in increased expression of LY96 mRNA CTD PMID:23876855 and PMID:29301061 sodium arsenite decreases methylation ISO Ly96 (Mus musculus) 6480464 sodium arsenite results in decreased methylation of LY96 gene CTD PMID:32068019 sodium arsenite decreases expression ISO Ly96 (Mus musculus) 6480464 sodium arsenite results in decreased expression of LY96 mRNA CTD PMID:31233874 sodium dichromate decreases expression ISO LY96 (Homo sapiens) 6480464 sodium bichromate results in decreased expression of LY96 mRNA CTD PMID:17685462 succimer multiple interactions ISO LY96 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LY96 mRNA CTD PMID:26378955 tartrazine multiple interactions ISO LY96 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of LY96 mRNA CTD PMID:33819548 temozolomide decreases expression ISO LY96 (Homo sapiens) 6480464 Temozolomide results in decreased expression of LY96 mRNA CTD PMID:31758290 tert-butyl hydroperoxide multiple interactions ISO LY96 (Homo sapiens) 6480464 1-(3 more ... CTD PMID:28063877 and PMID:29111459 testosterone multiple interactions ISO LY96 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of LY96 mRNA CTD PMID:21592394 testosterone increases expression ISO LY96 (Homo sapiens) 6480464 Testosterone results in increased expression of LY96 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO Ly96 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of LY96 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane decreases expression ISO Ly96 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of LY96 mRNA CTD PMID:29987408 tetrachloromethane multiple interactions ISO Ly96 (Mus musculus) 6480464 [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of LY96 mRNA CTD PMID:29987408 thalidomide decreases expression ISO Ly96 (Mus musculus) 6480464 Thalidomide results in decreased expression of LY96 mRNA CTD PMID:26006729 and PMID:26217789 titanium dioxide increases expression ISO Ly96 (Mus musculus) 6480464 titanium dioxide results in increased expression of LY96 mRNA CTD PMID:23557971 triclosan decreases expression ISO LY96 (Homo sapiens) 6480464 Triclosan results in decreased expression of LY96 mRNA CTD PMID:34681664 tris(2-butoxyethyl) phosphate affects expression ISO LY96 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of LY96 mRNA CTD PMID:29024780 troglitazone increases expression ISO LY96 (Homo sapiens) 6480464 troglitazone results in increased expression of LY96 mRNA CTD PMID:25572481 tungsten increases expression ISO Ly96 (Mus musculus) 6480464 Tungsten results in increased expression of LY96 mRNA CTD PMID:30912803 valproic acid decreases expression ISO LY96 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LY96 mRNA CTD PMID:29154799 vincristine increases expression ISO LY96 (Homo sapiens) 6480464 Vincristine results in increased expression of LY96 mRNA CTD PMID:23649840 zinc atom affects expression ISO LY96 (Homo sapiens) 6480464 Zinc affects the expression of LY96 mRNA CTD PMID:16979875 zinc(0) affects expression ISO LY96 (Homo sapiens) 6480464 Zinc affects the expression of LY96 mRNA CTD PMID:16979875